Tslp Signaling In Neuroinflammation represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications.
Thymic stromal lymphopoietin (TSLP) is a cytokine that plays a critical role in immune regulation and has been increasingly recognized for its involvement in neuroinflammation and neurodegenerative diseases. Originally identified in the thymus, TSLP is now known to be produced by various cell types including epithelial cells, astrocytes, and microglia in the central nervous system. [1]
| Property | Value | [2]
|----------|-------| [3]
| Cytokine | Thymic stromal lymphopoietin | [4]
| Gene | TSLP (LOC: 5q22.1) | [5]
| Receptor | TSLPR + IL-7Rα | [6]
| Signaling | JAK1/STAT5, PI3K/AKT, MAPK | [7]
| Cell Sources | Epithelial cells, astrocytes, microglia, neurons | [8]
TSLP signals through a heterodimeric receptor complex: [9]
Upon TSLP binding, three major pathways are activated:
JAK1/STAT5 Pathway
PI3K/AKT Pathway
MAPK/ERK Pathway
TSLP modulates microglial function through multiple mechanisms:
TSLP affects astrocyte responses in several ways:
TSLP can directly affect neurons:
TSLP is elevated in AD brains and contributes to disease progression:
Research shows TSLP levels correlate with:
In PD, TSLP plays a significant role:
TSLP is involved in MS pathophysiology:
Emerging evidence suggests TSLP involvement:
| Variant | Function | Disease Association |
|---|---|---|
| rs1890618 | Promoter polymorphism | Asthma, AD risk |
| rs1837253 | Expression QTL | Neuroinflammation |
| rs1146674 | 3'UTR variant | Autoimmune disease |
Genetic variants in CRLF2 affect:
| Agent | Target | Development Status | Indication |
|---|---|---|---|
| Tezepelumab | TSLP | Approved (2021) | Severe asthma |
| CSJ-117 | TSLP | Phase 2 | Atopic dermatitis |
| AK-120 | TSLP | Preclinical | Autoimmune disease |
For neuroinflammation, novel approaches include:
Challenges in CNS targeting:
The study of Tslp Signaling In Neuroinflammation has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
🔴 Low Confidence
| Dimension | Score |
|---|---|
| Supporting Studies | 10 references |
| Replication | 0% |
| Effect Sizes | 25% |
| Contradicting Evidence | 0% |
| Mechanistic Completeness | 50% |
Overall Confidence: 31%